Log in

NASDAQ:RVNCRevance Therapeutics Earnings Date, Estimates & History

+0.03 (+0.22 %)
(As of 04/3/2020 04:00 PM ET)
Today's Range
Now: $13.69
50-Day Range
MA: $20.03
52-Week Range
Now: $13.69
Volume558,031 shs
Average Volume1.04 million shs
Market Capitalization$780.74 million
P/E RatioN/A
Dividend YieldN/A


Revance Therapeutics (NASDAQ:RVNC) Earnings Information

Revance Therapeutics last announced its earnings results on February 24th, 2020. The biopharmaceutical company reported ($0.99) EPS for the quarter, missing the consensus estimate of ($0.97) by $0.02. The business had revenue of $0.09 million for the quarter, compared to analyst estimates of $5.35 million. Revance Therapeutics has generated ($3.67) earnings per share over the last year. Revance Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 13th, 2020 based off prior year's report dates.

Revance Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Revance Therapeutics (NASDAQ:RVNC) Earnings Estimates

2020 EPS Consensus Estimate: ($3.81)
2021 EPS Consensus Estimate: ($1.59)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.97)($0.81)($0.91)
Q2 20203($1.07)($0.79)($0.96)
Q3 20203($1.14)($0.73)($1.00)
Q4 20203($1.27)($0.64)($0.94)
Q1 20212($0.76)($0.56)($0.66)
Q2 20212($0.57)($0.50)($0.54)
Q3 20212($0.35)($0.30)($0.33)
Q4 20211($0.07)($0.07)($0.07)

Revance Therapeutics (NASDAQ RVNC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/24/2020Q4 2019($0.97)($0.99)($0.99)$5.35 million$0.09 millionTranscript
11/4/2019Q3 2019($0.96)($0.96)($0.96)$0.40 million$0.05 millionTranscript
8/5/2019Q2 2019($0.86)($0.86)($0.86)$0.87 millionTranscript
5/8/20193/31/2019($0.83)($0.85)($0.85)$1.85 million$0.28 millionN/A
2/26/2019Q4 2018($0.94)($1.12)($1.12)$1.96 million$0.49 millionN/A
11/1/20189/30/2018($0.95)($0.91)($0.91)$0.49 million$2.36 millionTranscript
8/2/2018Q2 2018($0.92)($0.94)($0.94)$0.93 million$0.69 millionN/A
5/8/2018Q1 2018($0.71)($0.97)($0.97)$0.15 million$0.19 millionN/A
2/28/2018Q4 2017($0.99)($1.14)($1.14)$0.09 million$0.04 millionTranscript
11/2/2017Q3 2017($0.95)($1.01)($1.01)$0.05 million$0.08 millionN/A
8/3/2017Q2 2017($0.93)($0.90)($0.90)$0.05 million$0.08 millionListen
5/9/2017Q1 2017($0.84)($0.94)($0.94)$0.07 million$0.08 millionListen
2/27/2017Q4 2016($0.82)($0.95)($0.95)$0.07 million$0.08 millionListen
11/3/2016Q3 2016($0.90)($0.64)($0.64)$0.08 million$0.08 millionN/A
8/4/2016Q2 2016($0.83)($0.88)($0.88)$0.06 million$0.80 millionN/A
5/9/2016Q1 2016($0.87)($0.71)($0.71)$0.08 million$0.08 millionListen
3/2/2016Q4 2015($0.92)($0.83)($0.83)$0.09 million$0.08 millionListen
11/9/2015Q3 2015($1.01)($0.81)($0.81)$0.10 million$0.08 millionN/A
8/6/2015Q2 2015($0.76)($0.71)($0.71)$0.15 million$0.08 millionN/A
5/13/2015Q1 2015($0.69)($0.65)($0.65)$0.15 million$0.08 millionListen
3/2/2015Q4 2014($0.53)($0.60)($0.60)$0.08 million$0.08 millionN/A
11/12/2014Q3 2014($0.60)($0.60)$0.08 millionN/A
8/12/2014Q2 2014($0.69)($0.69)$0.08 millionN/A
5/13/2014Q1 2014($1.93)($1.93)$0.16 millionListen
3/26/2014Q4 2013($47.11)($47.11)$0.31 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel